As the leading health economics and outcomes research (HEOR) professional society, ISPOR has a responsibility to establish a uniform, harmonized international code for ethical conduct. ISPOR has updated its 2008 Code of Ethics to reflect the current research environment. This code addresses what is acceptable and unacceptable in research, from inception to the dissemination of its results. There are nine chapters: 1 - Introduction; 2 - Ethical Principles respect, beneficence and justice with reference to a non-exhaustive compilation of international, regional, and country-specific guidelines and standards; 3 - Scope HEOR definitions and how HEOR and the Code relate to other research fields; 4 - Research Design Considerations primary and secondary data related issues, e.g., participant recruitment, population and research setting, sample size/site selection, incentive/honorarium, administration databases, registration of retrospective observational studies and modeling studies; 5 - Data Considerations privacy and data protection, combining, verification and transparency of research data, scientific misconduct, etc.; 6 - Sponsorship and Relationships with Others (roles of researchers, sponsors, key opinion leaders and advisory board members, research participants and institutional review boards (IRBs) / independent ethics committees (IECs) approval and responsibilities); 7 - Patient Centricity and Patient Engagement new addition, with explanation and guidance; 8 - Publication and Dissemination; and 9 - Conclusion and Limitations.
Drug safety issues do not respect national borders. Hence, addressing a safety question may necessitate globally coordinated efforts between regulatory authorities and market authorization holders (MAHs) to draw reliable conclusions. Regulatory authorities have shared responsibility with MAHs sponsoring postmarketing nonintervention studies in determining study goals and design. Their shared accountabilities include what will be investigated and how the data will be retrieved to ensure appropriate study quality required for regulatory decision making. The need for a harmonized framework and ethical standards for postmarketing observational studies is well recognized but has been lacking even among the United States, European Union, and Japan, which are so-called International Conference on Harmonisation (ICH) regions. A recent update of the Council for International Organizations of Medical Sciences International Ethical Guidelines for Health-Related Research Involving Humans provides further clarification on provisions for informed consent and the role of research ethics committees. However, without incorporation into legislative structures, the future impact of these guidelines is uncertain. This lack of harmonization leads to a complex and uncertain framework for ethical review and for participant informed consent, resulting in numerous inefficiencies in the regulatory postmarketing observational studies. The regulatory frameworks for postmarketing observational studies conducted under the auspices of regulatory agencies in the 3 regions are reviewed, with a focus on ethical requirements and opportunities for efficiencies.
Intra class correlation coefficients between the countries were high: from 0.89 (England vs. US) through 0.99 (Canada vs. US). ConClusions: This proof of concept study indicates that computer-based choice tasks for the EQ-5D-5L in the general population are feasible and parameter of the choice tasks estimates are generally consistent and logical, and the estimated values are largely consistent between the 4 countries.
THOUGH Dr. B. M. Hobby (1931, Trans. ent. Soc. S. Eng. 6 : 1-42) was able to collect 91 records of Machimus atricapillus Fallen with prey, no previous attempt has been made to study a population of the species in one locality.Therefore, when in Cornwall in August, 1941, I found the species to be common in a stretch of about 400 yards of a hedge bordering a wood a t Lelant, I collected as many specimens with prey as I could.The fly was rarely seen except on sunny days. It was found on branches and trunks of trees, telegraph poles and sunny leaves of plants from 1 to 10 feet off the ground. The favourite attitude taken up by the fly was to lie on one side with legs outstretched. Whether this was to enable the sun to shine along the whole length of the body or to keep better watch I could not tell. Sunny patches were preferred for resting and invariably the prey was brought to a sunny spot. The Asilid would alight on a telegraph pole on which were massed a hundred or so Musca corvina, 50 Pollenia rudis and perhaps three or four of its own species. Though several hours were devoted to the watching of the species I did not once see an attempt to capture a resting fly. All captures were flying insects, sometimes made by means of a " capture dart )' but occasionally when just about to alight after a patrol. At these times I imagine the Machimus would suddenly catch sight of a fly alighting and drop upon it. Though movement brought death to the victim, speedy and erratic flight brought safety. The commonest insects flying a t the time were Musca corvina, Pollenia rudis and Eumerus tuberculntus Rondani. Eumerus has a speedy erratic flight as it seeks its host plants. Musca, though fast, is steadier in flight, and Pollenia is fairly slow. No Eumerus was seen to be captured, but Pollenia was a frequent victim. Other slow flyers captured included Xyrphus balteatus, Melanostoma scalare and Beris vallata. Capture darts and flying attacks were made a t pieces of passing, falling leaves and at large wasps, but on close approach the Asilid would not press home its attack. As to colour of prey, both dull and brightly-hued insects were taken.Several times I had a pill-box over captor and prey almost as they alighted and the Asilid generally dropped as if dead. Though the victim would also slide inert over the floor of the box, the Asilid alone recovered. This feigning of death was not a regular habit although it occurred several times.
surveillance data collection. Such are defined as an aircraft without a human pilot on board, operated either autonomously by computer or under remote control by a human pilot. Methods: We performed a targeted literature search for medical applications of UAS and rank-ordered strengths and weaknesses according to emerging applications and corresponding difficulty, feasibility and cost. Results: Based on secondary sources, we report conceptual factors that can contribute to the practicality and efficiency of UAS in emergency medical situations. These were 1) frequency of occurrence, 2) time-sensitivity of occurrence, 3) rurality and complex terrain, 4) financial impact and 5) cultural acceptance. The results of our matrix point to a gradation of accepted uses for UAS with the variance in geographical location and urgency directly relating to an increase in operation costs. It is well known that natural disasters are increasing in frequency and intensity. Salient platforms for using UAS in medical delivery would be in the areas of natural and combative disaster relief. During these occurrences the use of UAS to aid in the medical relief could be a great asset. ConClusion: Our model illustrates how Big Data can be leveraged to improve ongoing quality and efficiency of UAS-delivered medical supplies, reduce time for delivery of supplies during times of natural disasters, and thus eschew our reliance on manned aircraft to assist in critical and non-critical medical operations.objeCtive: We propose a paradigm and ranking system for potential medical applications of unmanned aircraft systems (collectively UAS). Over the past three decades, UAS have become a vital component to our armed forces, used notably for combat but also commonly used for work in intelligence, reconnaissance and
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.